Principal Financial Group’s Achillion Pharmaceuticals, Inc. ACHN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2020
Q1 | – | Sell |
-10,535
| Closed | -$64K | – | 2284 |
|
2019
Q4 | $64K | Sell |
10,535
-23,286
| -69% | -$141K | ﹤0.01% | 2203 |
|
2019
Q3 | $122K | Buy |
33,821
+12,524
| +59% | +$45.2K | ﹤0.01% | 2172 |
|
2019
Q2 | $57K | Sell |
21,297
-11,362
| -35% | -$30.4K | ﹤0.01% | 2203 |
|
2019
Q1 | $97K | Sell |
32,659
-2,443
| -7% | -$7.26K | ﹤0.01% | 2157 |
|
2018
Q4 | $56K | Sell |
35,102
-2,063
| -6% | -$3.29K | ﹤0.01% | 2199 |
|
2018
Q3 | $137K | Sell |
37,165
-1,435
| -4% | -$5.29K | ﹤0.01% | 2209 |
|
2018
Q2 | $109K | Sell |
38,600
-4,328
| -10% | -$12.2K | ﹤0.01% | 2221 |
|
2018
Q1 | $159K | Buy |
42,928
+5,157
| +14% | +$19.1K | ﹤0.01% | 2129 |
|
2017
Q4 | $108K | Buy |
37,771
+22,375
| +145% | +$64K | ﹤0.01% | 2181 |
|
2017
Q3 | $69K | Sell |
15,396
-3,053
| -17% | -$13.7K | ﹤0.01% | 2156 |
|
2017
Q2 | $85K | Sell |
18,449
-3,058
| -14% | -$14.1K | ﹤0.01% | 2201 |
|
2017
Q1 | $91K | Hold |
21,507
| – | – | ﹤0.01% | 2147 |
|
2016
Q4 | $89K | Buy |
21,507
+427
| +2% | +$1.77K | ﹤0.01% | 2165 |
|
2016
Q3 | $171K | Buy |
21,080
+251
| +1% | +$2.04K | ﹤0.01% | 2058 |
|
2016
Q2 | $162K | Buy |
20,829
+253
| +1% | +$1.97K | ﹤0.01% | 2053 |
|
2016
Q1 | $159K | Buy |
20,576
+146
| +0.7% | +$1.13K | ﹤0.01% | 2048 |
|
2015
Q4 | $220K | Buy |
20,430
+541
| +3% | +$5.83K | ﹤0.01% | 2031 |
|
2015
Q3 | $137K | Sell |
19,889
-378
| -2% | -$2.6K | ﹤0.01% | 2077 |
|
2015
Q2 | $180K | Buy |
20,267
+670
| +3% | +$5.95K | ﹤0.01% | 2057 |
|
2015
Q1 | $193K | Buy |
19,597
+2,761
| +16% | +$27.2K | ﹤0.01% | 2035 |
|
2014
Q4 | $206K | Sell |
16,836
-4,626
| -22% | -$56.6K | ﹤0.01% | 2030 |
|
2014
Q3 | $214K | Buy |
+21,462
| New | +$214K | ﹤0.01% | 2013 |
|
2013
Q4 | – | Sell |
-335,235
| Closed | -$1.01M | – | 2325 |
|
2013
Q3 | $1.01M | Sell |
335,235
-196,058
| -37% | -$592K | ﹤0.01% | 1743 |
|
2013
Q2 | $4.35M | Buy |
+531,293
| New | +$4.35M | 0.01% | 1290 |
|